Search research articles
Contact Us
Filters
Showing results (181-190 of 221) with videos related to
Page
of 23
Sort By:
JAMA Oncology
|
January 3, 2020
Stereotactic Ablative Radiotherapy for the Management of Spinal Metastases: A Review
Rachel M Glicksman, Michael C Tjong, Wellington F P Neves-Junior, et al.
JCO Precision Oncology
|
June 6, 2025
Cross-Comparison Individual Patient-Level Analysis of Three Gene Expression Signatures in Localized Prostate in Over 50,000 Men
Angela Y Jia, Yilun Sun, Maitry Patel, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 25, 2024
Erratum to: Spratt DE, Liu VYT, Michalski J, Davicioni E, Berlin A, Simko JP, Efstathiou JA, Tran PT, Sandler HM, Hall WA, Thompson DJS, Parliament MB, Dayes IS, Correa RJM, Robertson JM, Gore EM, Doncals DE, Vigneault E, Souhami L, Karrison TG, Feng FY. Genomic classifier performance in intermediate-risk prostate cancer: results from NRG Oncology/RTOG 0126 randomized phase 3 trial. Int J Radiat Oncol Biol Phys 2023;117:370-377
Daniel E Spratt, Vinnie Y T Liu, Jeff Michalski, et al.
European Urology
|
January 9, 2021
The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited
Matthew P Deek, Kim Van der Eecken, Ryan Phillips, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 3, 2023
Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial
Daniel E Spratt, Vinnie Y T Liu, Jeff Michalski, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 19, 2021
An Expert Review on the Combination of Relugolix With Definitive Radiation Therapy for Prostate Cancer
Soumyajit Roy, Nicholas G Zaorsky, Hilary P Bagshaw, et al.
The Journal of Urology
|
August 29, 2018
International Multicenter Validation of an Intermediate Risk Subclassification of Prostate Cancer Managed with Radical Treatment without Hormone Therapy
Alejandro Berlin, Fabio Y Moraes, Noelia Sanmamed, et al.
European Urology Oncology
|
April 3, 2024
Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate Cancer
Matthew P Deek, Philip Sutera, Yuezhou Jing, et al.
Physics in Medicine and Biology
|
June 6, 2025
Roadmap: medical physics technologies in brachytherapy
William Y Song, Michael Roumeliotis, Junghoon Lee, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 7, 2024
Validation of an artificial intelligence-based prognostic biomarker in patients with oligometastatic Castration-Sensitive prostate cancer
Jarey H Wang, Matthew P Deek, Adrianna A Mendes, et al.
Page
of 23
Search research articles
Search
Showing results (181-190 of 221) with videos related to
Sort By:
Page
of 23
JAMA Oncology
|
January 3, 2020
Stereotactic Ablative Radiotherapy for the Management of Spinal Metastases: A Review
Rachel M Glicksman, Michael C Tjong, Wellington F P Neves-Junior, et al.
JCO Precision Oncology
|
June 6, 2025
Cross-Comparison Individual Patient-Level Analysis of Three Gene Expression Signatures in Localized Prostate in Over 50,000 Men
Angela Y Jia, Yilun Sun, Maitry Patel, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 25, 2024
Erratum to: Spratt DE, Liu VYT, Michalski J, Davicioni E, Berlin A, Simko JP, Efstathiou JA, Tran PT, Sandler HM, Hall WA, Thompson DJS, Parliament MB, Dayes IS, Correa RJM, Robertson JM, Gore EM, Doncals DE, Vigneault E, Souhami L, Karrison TG, Feng FY. Genomic classifier performance in intermediate-risk prostate cancer: results from NRG Oncology/RTOG 0126 randomized phase 3 trial. Int J Radiat Oncol Biol Phys 2023;117:370-377
Daniel E Spratt, Vinnie Y T Liu, Jeff Michalski, et al.
European Urology
|
January 9, 2021
The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited
Matthew P Deek, Kim Van der Eecken, Ryan Phillips, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 3, 2023
Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial
Daniel E Spratt, Vinnie Y T Liu, Jeff Michalski, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 19, 2021
An Expert Review on the Combination of Relugolix With Definitive Radiation Therapy for Prostate Cancer
Soumyajit Roy, Nicholas G Zaorsky, Hilary P Bagshaw, et al.
The Journal of Urology
|
August 29, 2018
International Multicenter Validation of an Intermediate Risk Subclassification of Prostate Cancer Managed with Radical Treatment without Hormone Therapy
Alejandro Berlin, Fabio Y Moraes, Noelia Sanmamed, et al.
European Urology Oncology
|
April 3, 2024
Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate Cancer
Matthew P Deek, Philip Sutera, Yuezhou Jing, et al.
Physics in Medicine and Biology
|
June 6, 2025
Roadmap: medical physics technologies in brachytherapy
William Y Song, Michael Roumeliotis, Junghoon Lee, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 7, 2024
Validation of an artificial intelligence-based prognostic biomarker in patients with oligometastatic Castration-Sensitive prostate cancer
Jarey H Wang, Matthew P Deek, Adrianna A Mendes, et al.
Page
of 23